abstract |
The subject matter of the present invention is a solid dispersion comprising an active ingredient chosen from the group consisting of selective modulators of the progesterone receptor, metabolites thereof and mixtures thereof, and a pharmaceutically acceptable polymeric excipient. The invention also relates to a pharmaceutical composition comprising said solid dispersion and to the therapeutic uses thereof. |